NovaBridge Biosciences

Yahoo Finance • 9 days ago

NovaBridge Appoints Biotech Leader, Emmett T. Cunningham, Jr, MD, PhD, MPH, as Vice Chairman of the Board to Further Accelerate Global Biotech Platform

Appointment is a positive endorsement of NovaBridge’s unique hub-and-spoke model and focus on creating shareholder value by accelerating the development of transformative medicines for patients around the worldAs a physician-entrepreneur a... Full story

Yahoo Finance • 22 days ago

Amazon downgraded, Roblox upgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Freedom Capital upgraded Roblox (RBLX)... Full story

Yahoo Finance • 2 months ago

NovaBridge to Ring the Nasdaq Opening Bell on Friday, January 2, 2026

NovaBridge Also Included in the Highly Regarded Nasdaq Biotech Index, Emphasizing its Position as an Industry Leader Opening the first trading session of the New Year marks an excellent beginning to 2026 for NovaBridgeInclusion in the Nas... Full story

Yahoo Finance • 3 months ago

NovaBridge Announces Promising Phase 1 Results For Ragistomig, 4-1BB X PD-L1 Bispecific Antibody

(RTTNews) - NovaBridge Biosciences (NBP), a global biotechnology platform company, together with co-developer ABL Bio, reported encouraging new data from the expanded Phase 1 dosing study of Ragistomig, a 4-1BB x PD-L1 bispecific antibody.... Full story

Yahoo Finance • 3 months ago

NovaBridge Announces Presentation of Ragistomig Expanded Phase 1 Data at ESMO-IO

Ragistomig is a 4-1BB X PD-L1 bispecific antibody, designed to treat patients who are relapsed or refractory to checkpoint inhibitors, a multi-billion dollar drug class hampered by widespread resistanceThe Phase 1 ragistomig study achieved... Full story

Yahoo Finance • 3 months ago

NovaBridge’s Visara Subsidiary Appoints Distinguished Ophthalmology Leaders as Chief Medical Officer and Scientific Advisory Board Chair to Drive VIS-101 Forward

Cadmus C. Rich, MD, MBA, as Chief Medical Officer, and Carlos Quezada-Ruiz, MD, FASRS, as Chair of the Scientific Advisory Board, bring invaluable clinical development expertise to VIS-101 ProgramThe ability to attract seasoned ophthalmolo... Full story